Anthera Pharmaceuticals Inc 4
4 · Anthera Pharmaceuticals Inc · Filed Mar 3, 2017
Insider Transaction Report
Form 4
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
- Award
Stock option (right to buy)
2017-03-03+100,000→ 100,000 totalExercise: $0.64Exp: 2027-03-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This stock option vests monthly in 48 equal installments. The vesting commencement date is December 6, 2016. This option will expire on March 3, 2027.